$ETST huge CBD distribution news just released!!
Earth Science Tech, Inc. Signs Distribution Agreement with Mr. Checkout for its New CBD Product Revamp Starting in 2018
By
Published: Dec 13, 2017 8:01 a.m. ET
Doral, FL, Dec 13, 2017 (GLOBE NEWSWIRE via COMTEX) --
Earth Science Tech, Inc. (otc pink:ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, signs distribution agreement with Mr. Checkout, beginning in 2018, and coinciding with the company's new CBD product revamp.
ETST looks to start the year strong, adding it's first major distributor to the already strong and growing team of representatives across the U.S. The company currently has 10 active representatives opening and managing accounts across the states, one of which recently joined in December and immediately began bringing in a good number of chain stores. The representatives have been very successful with health food stores and clinics. ETST has signed a distribution agreement with Mr. Checkout to open and manage major retailers and stores within the U.S., which substantially expands the company's reach.
Mr. Checkout, as featured on ABC's Shark Tank, is a national group of independent distributors, full-line grocery distributes, and convenience stores. Mr. Checkout represents products in over 60 major retailers throughout the U.S. and approximately 55,000 stores. A few of Mr. Checkout's accounts are Walgreens, CVS, Walmart, Wholefoods Market, and Target, just to name a few.
Gabriel Aviles, ETST's Chief Sales Officer & Director states, "I feel that we have finally put together a solid productive team of representatives that we needed to continue expanding our presence in health shops and clinics. Now, with Mr. Checkout, we will be able to take our presence and sales to the next level, entering larger retailers and many stores. 2018 looks to be starting off very strong with our new product revamp, marketing and education strategy, and sales channel."
ETST's President, Director, & COO concludes with, "Gabriel has done a remarkable job building our sales team and expanding our presence across the U.S. I have no doubt that 2018 is going to be a solid year of growth for us, with all we have initiating as early as January alone, with our CBD products. Our MSN-2 medical device globalization strategy is still on track, and we are currently in talks with institutional investors thanks to our planned up-listing in Q1 2018. I plan on sharing further updates as they progress on the MSN-Medical device, IP patents, CBD based pharmaceutical generic drugs, and our new CBD formula opioid clinical trials as they progress."
